EVM
CDMO

Eaton Vance Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Eaton Vance Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-365
Closed -$11K – 2788
2021
Q4 		$11K Buy
+365
New +$10.4K ﹤0.01% 2522
2021
Q2 		– Sell
-434
Closed -$8K – 3057
2021
Q1 		$8K Buy
+434
New +$7.21K ﹤0.01% 2433

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Eaton Vance Management's CDMO Position: Q1 2022 in Review

Eaton Vance Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2022, closing a stake of 365 shares — an estimated $11K sold.

Eaton Vance Management first reported a position in CDMO in Q1 2021 and held it in 2 quarters. The position peaked at $11K in Q4 2021. 193 funds tracked by Wall St. Rank hold CDMO as of Q1 2022.

  • Eaton Vance Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Eaton Vance Management sold 365 Avid Bioservices, Inc. Common Stock shares in Q1 2022, an estimated $11K.
  • Eaton Vance Management first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Eaton Vance Management's Avid Bioservices, Inc. Common Stock position peaked at $11K in Q4 2021.
  • 193 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2022.

Based on Eaton Vance Management's 13F filing for Q1 2022, filed 16 May 2022.